NICK ARVANITIDIS

Oct 2 • MENTORS • 1941 Views • No Comments on NICK ARVANITIDIS

Investor

ArvanitidisNick (1)

 

Professional experience

Semi Retired 1995 – Present (20 years) Menlo Park, CA
Retired from the corporate world since 1995, he has been an active investor in startups, financial markets and real estate. He has provided guidance to and invested in several start ups over the past 20 years. He also started the Silicon Valley Greek Seed Fund and was its founding Executive Chairman.

Founder, CEO – Sequus Pharmaceuticals 1981 – 1995 (14 years)
Sequus Pharmaceuticals was a drug delivery company with focus on treatments for cancer and systemic infections. Among the company’s greatest achievements was the
development of Doxorubicin liposome injection (DOXIL). DOXIL is now approved worldwide for the treatment of ovarian and breast carcinoma. The company was
financed with Venture Capital, Private Equity and Corporate deals until it had a successful NASDAQ IPO in 1987; the company was acquired by ALZA Corp. in 1998;
and ALZA was acquired by J&J in 1999.

Founder, CEO – Intasa Inc. 1968 – 1983 (15 years)
A management consulting company with offices in Menlo Park, Washington D.C. and Hawaii that focused on infrastructure / natural resource planning, growth management and public policy.

 

Stanford University
PhD, Management Science and Engineering, 1964 – 1967

Stanford University
MS, Electrical Engineering, 1963 – 1964

Seattle University
BS, Electrical Engineering, 1959 – 1963

 

Related Posts

Comments are closed.

« »